Histologic transformation of lung cancer during pembrolizumab therapy: A case report

Immune checkpoint inhibitors that block the programmed death 1/programmed death ligand 1 pathways are widely used to treat advanced lung cancers. There are seldom cases of histologic transformation reported after treatment with immunotherapy. Here, we report the case of a 69‐year‐old man with stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Xiaoyan, You, Yan, Zhang, Xiaotong, Wang, Hanping, Wang, Mengzhao, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049493/
https://www.ncbi.nlm.nih.gov/pubmed/31944570
http://dx.doi.org/10.1111/1759-7714.13312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049493/
https://www.ncbi.nlm.nih.gov/pubmed/31944570
http://dx.doi.org/10.1111/1759-7714.13312

Ejemplares similares